1. Home
  2. EOLS vs CRML Comparison

EOLS vs CRML Comparison

Compare EOLS & CRML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EOLS
  • CRML
  • Stock Information
  • Founded
  • EOLS 2012
  • CRML N/A
  • Country
  • EOLS United States
  • CRML United States
  • Employees
  • EOLS N/A
  • CRML N/A
  • Industry
  • EOLS Biotechnology: Pharmaceutical Preparations
  • CRML
  • Sector
  • EOLS Health Care
  • CRML
  • Exchange
  • EOLS Nasdaq
  • CRML NYSE
  • Market Cap
  • EOLS 1.1B
  • CRML 620.0M
  • IPO Year
  • EOLS 2018
  • CRML N/A
  • Fundamental
  • Price
  • EOLS $16.63
  • CRML $7.02
  • Analyst Decision
  • EOLS Strong Buy
  • CRML
  • Analyst Count
  • EOLS 6
  • CRML 0
  • Target Price
  • EOLS $22.60
  • CRML N/A
  • AVG Volume (30 Days)
  • EOLS 644.7K
  • CRML 11.5K
  • Earning Date
  • EOLS 11-05-2024
  • CRML 11-15-2024
  • Dividend Yield
  • EOLS N/A
  • CRML N/A
  • EPS Growth
  • EOLS N/A
  • CRML N/A
  • EPS
  • EOLS N/A
  • CRML N/A
  • Revenue
  • EOLS $237,260,000.00
  • CRML N/A
  • Revenue This Year
  • EOLS $34.62
  • CRML N/A
  • Revenue Next Year
  • EOLS $33.33
  • CRML N/A
  • P/E Ratio
  • EOLS N/A
  • CRML N/A
  • Revenue Growth
  • EOLS 40.71
  • CRML N/A
  • 52 Week Low
  • EOLS $7.44
  • CRML $5.32
  • 52 Week High
  • EOLS $17.82
  • CRML $22.50
  • Technical
  • Relative Strength Index (RSI)
  • EOLS 52.28
  • CRML 47.22
  • Support Level
  • EOLS $16.38
  • CRML $6.61
  • Resistance Level
  • EOLS $17.57
  • CRML $6.94
  • Average True Range (ATR)
  • EOLS 0.77
  • CRML 0.27
  • MACD
  • EOLS -0.04
  • CRML 0.08
  • Stochastic Oscillator
  • EOLS 42.51
  • CRML 47.00

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

About CRML CRITICAL METALS CORPORATION

Critical Metals Corp is a company whose business activities are lithium exploration. It has one operating segment which relate to mineral exploration.

Share on Social Networks: